Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Recruiting now
Conditions studied: AV Block Complete, Tricuspid Regurgitation (TR)
In brief
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Key facts
- Study ID
- NCT06814574
- Run by
- Deutsches Herzzentrum Muenchen
- People needed
- 25
- Starts
- 2024-01-01
- Expected to finish
- 2025-01-31
- Last updated by the study team
- 2025-02-07
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Transcatheter Tricuspid Valve Replacement
You may not qualify if…
- no defined exclusion criteria
Where it is running
- Deutsches Herzzentrum München — München, Bavaria, Germany (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.